--- Chain 10 for Question 102 ---
Status: PRUNED
Is Active Flag: False
Finish Reason: worker_terminated_unexpectedly
Reasoning Complete Flag: True
Error: None
Prompt Tokens: 439
Completion Tokens: 671
Completed Thoughts: 3
Pruned at Analysis Step: 6
Final Processed Boundaries: [0, 550, 1413]

--- Full Content ---
Okay, so I've got this pretty complex question about molecular biology and genetics, specifically dealing with transmembrane receptors and how they're being expressed in a mouse model. Hmm, let me try to unpack this step by step.

So, the question is about a ligand-receptor pair expressed in neural crest cells. The setup involves a bicistronic lox-Cre vector. Bicistronic means it has two coding regions, right? So the vector has the ligand ORF at the 5' end, fused to mCherry, and the receptor ORF at the 3' end, fused to eGFP at the C-terminus.

Wait, the ligand is under the CBA promoter. I remember that CBA is a strong promoter, and it's constitutive, so it should drive the ligand's expression. Then, between the ligand ORF and mCherry, there's a stop in a loxP-stop-loxP cassette. That means without Cre, the ligand would be expressed, but mCherry would be blocked because of the stop cassette. Oh, but wait, the mCherry is fused to the ligand ORF, so maybe that's a way to track ligand expression.

The receptor is after the IRES element. IRES allows for internal ribosome entry, meaning it can drive the expression of the downstream gene, which in this case is the receptor. So under the IRES, the receptor would be expressed. But between the receptor and eGFP, there's a stop cassette using lox2272. So, without Cre, the receptor would be expressed, but eGFP wouldn't? Or maybe the other way around.

Wait, the vector is bicistronic, so it's a single transcript that contains both ORFs. The first ORF (ligand) is under CBA, and the second (receptor) is under IRES. So the ligand is expressed from the CBA promoter, and the receptor is co-expressed from the same transcript, but via IRES.

The stop cassettes are important. So between ligand and mCherry, the loxP-stop-loxP. So, without Cre, the ligand is expressed, but the stop will prevent mCherry from being expressed. But when Cre is present, it will excise the stop, allowing mCherry to be expressed downstream of the ligand. Similarly, the receptor and eGFP have the lox2272 cassette. So, if Cre is present, it would excise the stop, allowing eGFP to be expressed after the receptor.

But wait, the setup says that the mouse model is homozygous for the construct in the wt background. Then they crossed it with SOX10-Cre hemizygous mice. SOX10-Cre is a transgenic line where Cre is under the control of SOX10 promoter, which is active in neural crest cells. So in the offspring, the Cre is active in neural crest cells, which should excise the stop cassettes.

So, in the offspring, the ligand and mCherry should be co-expressed, and the receptor and eGFP should be co